130 related articles for article (PubMed ID: 10544118)
1. The FeLV-945 LTR confers a replicative advantage dependent on the presence of a tandem triplication.
Prabhu S; Lobelle-Rich PA; Levy LS
Virology; 1999 Oct; 263(2):460-70. PubMed ID: 10544118
[TBL] [Abstract][Full Text] [Related]
2. Regulation of FeLV-945 by c-Myb binding and CBP recruitment to the LTR.
Finstad SL; Prabhu S; Rulli KR; Levy LS
Virol J; 2004 Sep; 1():3. PubMed ID: 15507152
[TBL] [Abstract][Full Text] [Related]
3. Function of a unique sequence motif in the long terminal repeat of feline leukemia virus isolated from an unusual set of naturally occurring tumors.
Athas GB; Lobelle-Rich P; Levy LS
J Virol; 1995 Jun; 69(6):3324-32. PubMed ID: 7745680
[TBL] [Abstract][Full Text] [Related]
4. Genetic determinants of feline leukemia virus-induced multicentric lymphomas.
Athas GB; Choi B; Prabhu S; Lobelle-Rich PA; Levy LS
Virology; 1995 Dec; 214(2):431-8. PubMed ID: 8553544
[TBL] [Abstract][Full Text] [Related]
5. Feline leukaemia virus LTR variation and disease association in a geographical and temporal cluster.
Chandhasin C; Lobelle-Rich P; Levy LS
J Gen Virol; 2004 Oct; 85(Pt 10):2937-2942. PubMed ID: 15448356
[TBL] [Abstract][Full Text] [Related]
6. Advances in understanding molecular determinants in FeLV pathology.
Levy LS
Vet Immunol Immunopathol; 2008 May; 123(1-2):14-22. PubMed ID: 18289704
[TBL] [Abstract][Full Text] [Related]
7. Unique long terminal repeat and surface glycoprotein gene sequences of feline leukemia virus as determinants of disease outcome.
Chandhasin C; Coan PN; Pandrea I; Grant CK; Lobelle-Rich PA; Puetter A; Levy LS
J Virol; 2005 May; 79(9):5278-87. PubMed ID: 15827142
[TBL] [Abstract][Full Text] [Related]
8. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.
Lichtenstein DL; Craigo JK; Leroux C; Rushlow KE; Cook RF; Cook SJ; Issel CJ; Montelaro RC
Virology; 1999 Oct; 263(2):408-17. PubMed ID: 10544113
[TBL] [Abstract][Full Text] [Related]
9. Feline leukemia virus variants in experimentally induced thymic lymphosarcomas.
Pandey R; Bechtel MK; Su Y; Ghosh AK; Hayes KA; Mathes LE; Roy-Burman P
Virology; 1995 Dec; 214(2):584-92. PubMed ID: 8553560
[TBL] [Abstract][Full Text] [Related]
10. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency.
Merezak C; Pierreux C; Adam E; Lemaigre F; Rousseau GG; Calomme C; Van Lint C; Christophe D; Kerkhofs P; Burny A; Kettmann R; Willems L
J Virol; 2001 Aug; 75(15):6977-88. PubMed ID: 11435578
[TBL] [Abstract][Full Text] [Related]
11. Sequence analysis of the putative viral enhancer in tissues from 33 cats with various feline leukemia virus-related diseases.
Jackson ML; Haines DM; Misra V
Vet Microbiol; 1996 Dec; 53(3-4):213-25. PubMed ID: 9008333
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
13. Identification and deletion of sequences required for feline leukemia virus RNA packaging and construction of a high-titer feline leukemia virus packaging cell line.
Burns CC; Moser M; Banks J; Alderete JP; Overbaugh J
Virology; 1996 Aug; 222(1):14-20. PubMed ID: 8806483
[TBL] [Abstract][Full Text] [Related]
14. Quantification of endogenous and exogenous feline leukemia virus sequences by real-time PCR assays.
Tandon R; Cattori V; Willi B; Lutz H; Hofmann-Lehmann R
Vet Immunol Immunopathol; 2008 May; 123(1-2):129-33. PubMed ID: 18295344
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the disease potential of a recombinant retrovirus containing Friend murine leukemia virus sequences and a unique long terminal repeat from feline leukemia virus.
Nishigaki K; Hanson C; Thompson D; Yugawa T; Hisasue M; Tsujimoto H; Ruscetti S
J Virol; 2002 Feb; 76(3):1527-32. PubMed ID: 11773427
[TBL] [Abstract][Full Text] [Related]
16. Regulation of gene expression directed by the long terminal repeats of feline leukemia viruses.
Nishigaki K; Endo Y; Matsumoto Y; Watari T; Goitsuka R; Tsujimoto H; Hasegata A
Leukemia; 1997 Apr; 11 Suppl 3():189-92. PubMed ID: 9209339
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor 1 activates the feline leukemia virus long terminal repeat but is posttranscriptionally down-regulated in leukemia cell lines.
Plumb M; Fulton R; Breimer L; Stewart M; Willison K; Neil JC
J Virol; 1991 Apr; 65(4):1991-9. PubMed ID: 1848314
[TBL] [Abstract][Full Text] [Related]
18. Isolation of a novel subgroup B feline leukemia virus from a cat infected with FeLV-A.
Boomer S; Gasper P; Whalen LR; Overbaugh J
Virology; 1994 Nov; 204(2):805-10. PubMed ID: 7941350
[TBL] [Abstract][Full Text] [Related]
19. Presence of Endogenous Viral Elements Negatively Correlates with Feline Leukemia Virus Susceptibility in Puma and Domestic Cat Cells.
Chiu ES; VandeWoude S
J Virol; 2020 Oct; 94(21):. PubMed ID: 32817213
[TBL] [Abstract][Full Text] [Related]
20. Endogenous Feline Leukemia Virus (FeLV) siRNA Transcription May Interfere with Exogenous FeLV Infection.
Chiu ES; McDonald CA; VandeWoude S
J Virol; 2021 Nov; 95(23):e0007021. PubMed ID: 34495702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
